How effective is Carboplatin for Lung Cancer - Small Cell? (a real world drug study)
Summary:
Overall ratings: 3.8/5 Long term ratings: 4/5
This is a phase IV clinical study of how effective Carboplatin (carboplatin) is for Lung cancer - small cell and for what kind of people. The study is created by eHealthMe from 5 Carboplatin users and is updated continuously.
What is Carboplatin?
Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.
What is Lung cancer - small cell?
Lung cancer - small cell (lung cancer) is found to be associated with 158 drugs and 536 conditions by eHealthMe. Check the latest studies of Lung cancer - small cell.
5 people are studied for taking Carboplatin in Lung cancer - small cell
Overall effectiveness (number of people):

Long term (1+ years) effectiveness (number of people):

Carboplatin effectiveness for Lung cancer - small cell (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 2
- high: 2
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 1
- very high: 0
Gender of people who take Carboplatin for Lung cancer - small cell *:
- female: 60 %
- male: 40 %
Age of people who take Carboplatin for Lung cancer - small cell *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 20 %
- 60+: 80 %
Who find Carboplatin more effective for Lung Cancer - Small Cell?
Gender of people who take Carboplatin for Lung cancer - small cell *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Carboplatin for Lung cancer - small cell *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 33.33 %
- 60+: 66.67 %
* Approximation only. Some reports may have incomplete information.
Do you take Carboplatin?
- You can start a phase IV clinical trial to monitor Carboplatin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Carboplatin (128,210 reports)
Treatments, associated drugs and conditions:
- Lung cancer - small cell (8,678 reports)
How the study uses the data?
The study is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Folvite and Aromasin - 21 seconds ago
- Pramine and Hypoaesthesia for Women aged 30-39 - 22 seconds ago
- Diovan and Sinusitis - Acute for Women aged 50-59 - 23 seconds ago
- Diovan and Sinus Infection for Women aged 50-59 - 24 seconds ago
- Drug Intolerance and drugs of ingredients of amitriptyline hydrochloride - 24 seconds ago
- Quinapril Hydrochloride and Lantus drug interactions for men aged 60+ - 24 seconds ago
- Diovan and Acute Sinusitis for Women aged 50-59 - 24 seconds ago
- Diovan and Sinusitis for Women aged 50-59 - 24 seconds ago
- Levothyroxine Sodium and Joint Swelling for Women aged 50-59 - 29 seconds ago
- Levothyroxine Sodium and Swelling Of Fingers for Women aged 50-59 - 30 seconds ago